Epidermal growth factor receptor: is it a feasible target for the treatment of osteosarcoma? (Q54475781)

30 May 2018

title

Epidermal growth factor receptor: is it a feasible target for the treatment of osteosarcoma? (English)

1 reference

30 May 2018

author name string

Jun Ah Lee

1

1 reference

30 May 2018

Yunmi Ko

2

1 reference

30 May 2018

Dong Ho Kim

3

1 reference

30 May 2018

Jung Sub Lim

4

1 reference

30 May 2018

Chang-Bae Kong

5

1 reference

30 May 2018

Wan Hyeong Cho

6

1 reference

30 May 2018

Dae-Geun Jeon

7

1 reference

30 May 2018

Soo-Yong Lee

8

1 reference

30 May 2018

Jae-Soo Koh

9

1 reference

30 May 2018

publication date

30 September 2012

1 reference

30 May 2018

Cancer Research and Treatment

published in

1 reference

30 May 2018

volume

44

1 reference

30 May 2018

issue

3

1 reference

30 May 2018

page(s)

202-209

1 reference

30 May 2018

Creative Commons Attribution-NonCommercial 3.0 Unported

copyright license

start time

30 September 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Epidermal growth factor receptor inhibitors in oncology

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Aberration of epidermal growth factor receptor expression in bone and soft-tissue tumors: protein overexpression, gene amplification and activation of downstream molecules

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

ZD1839 (Iressa) in non-small cell lung cancer

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma.

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3467424

Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma

2 November 2018

1 reference

12 December 2020

Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferating activities and p53 expression

1 reference

12 December 2020

Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol

1 reference

12 December 2020

Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase

1 reference

12 December 2020

Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome

1 reference

12 December 2020

10.4143/CRT.2012.44.3.202

Identifiers

DOI

1 reference

30 May 2018

PMCID

3467424

1 reference

30 May 2018

PubMed ID

23091447

1 reference

30 May 2018